StdInChIKey Ref stdinchicite correct chemspider StdInChIKey KBOPZPXVLCULAV UHFFFAOYSA N Mesalazine ... http www3.interscience.wiley.com cgi bin fulltext 117987903 HTMLSTART accessdate 2009 12 20 ref Mesalazine ... drug PA450384 tabview tab2&subtab 31 mesalazine . PharmGKB. ref As a derivative of salicylic acid , 5 ... 2009 Mesalazine is formulated for oral ingestion as tablets or granules, and for rectal administration ... formulations of mesalazine have published data to suggest that once daily dosing is sufficient in ulcerative ... pH such as lactulose , a laxative will possibly affect the binding of mesalazine in the bowel and will therefore ... , aplastic anaemia , leukopenia , neutropenia , thrombocytopenia Mesalazine avoids the sulphonamide ... for treating ulcerative colitis . Reuters. February 16, 2007. http www.ccfa.org reuters mesalazine Once daily mesalazine effective in active ulcerative colitis study . Reuters. January, 30, 2009 ... hr Mesalazin it Mesalazina he nl Mesalazine ja pl Mesalazyna pt Aminossalicilato ru ... more details
DISPLAYTITLE C sub 7 sub H sub 7 sub NO sub 3 sub The molecular formula C sub 7 sub H sub 7 sub NO sub 3 sub molar mass 153.135 g mol may refer to Aminosalicylic acid 3 Hydroxyanthranilic acid Mesalazine 3 Nitrobenzyl alcohol Salicylhydroxamic acid MolFormDisambig Short pages monitor This long comment was added to the page to prevent it being listed on Special Shortpages. It and the accompanying monitoring template were generated via Template Longcomment. Please do not remove the monitor template without removing the comment as well. fr C7H7NO3 ... more details
by 5 aminosalicylic acid 5 ASA , the active ingredient in Mesalazine. 5 ASA is produced from ... Mesalazine , also known as 5 aminosalicylic acid, mesalamine, or 5 ASA. Brand names include .... Standard treatment for active disease includes Mesalazine suppositories and cortisone foam Cortifoam . Mesalazine 1 g SUPP QHS or Cortifoam QHS BID is continued until remission, with response seen usually within three weeks. Maintenance therapy is with Mesalazine 1g QHS or Q3HS. Those ..., Mesalazine, or Colazol, although they are not as effective as suppositories for proctitis. Maintenance therapy is not recommended for those with a first episode that responded to the Mesalazine ..., from the rectum up the left side of the patient. Patients often respond to topical agents alone, such as Mesalazine, or hydrocortisone enemas. Again, the Mesalazine is preferred for maintenance therapy. Initially a 4 g Mesalazine enema Rowasa is given nightly. If response is seen, the enemas can be tapered to every third night. If no response, a morning Mesalazine, or hydrocortisone enema Cortenema ..., such as sulfasalazine, Mesalazine Asacol, Pentasa , olsalazine Dipentum , or balsalazide Colazal . If still no response, dose should be increased to maximum sulfasalazine maxes at 4 6 g day, Mesalazine ... absorption. If oral Mesalazine is still not working, prednisone should be given, starting at 40 ... or pancolitis . Patients usually require a combination of oral Mesalazine or sulfasalazine along with topical Mesalazine or steroid enemas. Oral prednisone 40 60  mg day should be given only in severe cases or if oral Mesalazine fails. Once remission is induced, maintenance therapy is with standard oral Mesalazine doses. Supplemental iron ferrous sulfate or ferrous gluconate may be given ... persist after 2 3 days, Mesalazine or hydrocortisone enemas daily or bid can be given. The use of antibiotics ... more details
Diversion colitis is an inflammation of the colon which can occur as a complication of ileostomy or colostomy , often occurring within the year following the surgery. It can also occur in a neovagina created by colovaginoplasty , sometimes several years after the original procedure. Despite the presence of a variable degree of inflammation the most suggestive histological feature remains the prominent lymphoid aggregates. The diagnosis cannot be safely reached without knowing the clinical story. ref Haboubi NY, Schofield. Reporting colonic biopsies in inflammatory conditions a new approach. Colorectal Disease 1999, 2 66 72 ref In many milder cases after ileostomy or colostomy, diversion colitis is left untreated and disappears naturally. If treatment is required, possible treatments include short chain fatty acid irrigation, steroid enemas and mesalazine . ref cite journal doi 10.1136 gut.32.9.1020 author Geraghty JM, Talbot IC title Diversion colitis histological features in the colon and rectum after defunctioning colostomy journal Gut volume 32 issue 9 pages 1020 3 year 1991 month September pmid 1916483 pmc 1379042 url http gut.bmj.com cgi pmidlookup?view long&pmid 1916483 ref References reflist Category Colitis ... more details
Infobox Disease Name PAGENAME Image Caption DiseasesDB 30087 ICD10 ICD9 ICDO OMIM MedlinePlus eMedicineSubj med eMedicineTopic 1351 MeshID D046730 Lymphocytic colitis , a subtype of microscopic colitis , is a rare condition characterized by chronic non bloody watery diarrhea . The colonoscopy is normal but the mucosal biopsy reveals an accumulation of lymphocytes in the colonic epithelium and connective tissue lamina propria . Collagenous colitis shares this feature but additionally shows a distinctive thickening of the subepithelial collagen table. The peak incidence of lymphocytic colitis is in persons over age 50 the disease affects women more than men. Causes No definite etiology has been determined. Some reports have implicated long term usage of Non steroidal anti inflammatory drugs NSAIDs , antidepressants specifically Sertraline Zoloft , and other drugs and overactive immune responses are also suspected. Treatment Over the counter antidiarrheal drugs are effective for many people with lymphocytic colitis. Anti inflammatory drugs, such as Salicylic acid salicylates may also help. Corticosteroids or Mesalazine s may be prescribed for people who do not respond to other drug treatment. The long term prognosis for this disease is not clear. See also Colitis Collagenous colitis External links http digestive.niddk.nih.gov ddiseases pubs collagenouscolitis index.htm Collagenous Colitis and Lymphocytic Colitis http www.diseasesdatabase.com umlsdef.asp?glngUserChoice 30087 Diseases Database http www.gpnotebook.co.uk simplepage.cfm?ID 1697972300 GPNotebook http www.emedicine.com med topic1351.htm eMedicine.com http www.merckmanuals.com home digestive disorders inflammatory bowel diseases ibd collagenous colitis and lymphocytic collitis.html Merck Manual References http hopkins gi.nts.jhu.edu pages latin templates index.cfm?pg disease1&disease 29&organ 6&lang id 1 Gasteroenterology and Hepatology Resource Center, Johns Hopkins Medical Institutes Digestive system disease ... more details
Drugbox Verifiedfields changed verifiedrevid 459514592 IUPAC name E 5 4 2 carboxyethylcarbamoyl phenyl diazenyl 2 hydroxybenzoic acid image Balsalazide.png Clinical data tradename Colazal Drugs.com drugs.com monograph colazal MedlinePlus a699052 pregnancy US B pregnancy category legal UK POM routes of administration Pharmacokinetic data bioavailability 1 protein bound 99 metabolism elimination half life 12hr Identifiers CASNo Ref cascite correct CAS CAS number Ref cascite correct ?? CAS number 80573 04 2 ATC prefix A07 ATC suffix EC04 ATC supplemental PubChem 5362070 DrugBank Ref drugbankcite changed drugbank DrugBank APRD00141 ChemSpiderID Ref chemspidercite correct chemspider ChemSpiderID 10662422 UNII Ref fdacite correct FDA UNII P80AL8J7ZP ChEBI Ref ebicite correct EBI ChEBI 267413 ChEMBL Ref ebicite changed EBI ChEMBL 102265 Chemical data C 17 H 15 N 3 O 6 molecular weight 357.318 g mol smiles O C O c1cc ccc1O N N c2ccc cc2 C O NCCC O O InChI 1 C17H15N3O6 c21 14 6 5 12 9 13 14 17 25 26 20 19 11 3 1 10 2 4 11 16 24 18 8 7 15 22 23 h1 6,9,21H,7 8H2, H,18,24 H,22,23 H,25,26 b20 19 InChIKey IPOKCKJONYRRHP FMQUCBEEBN StdInChI Ref stdinchicite correct chemspider StdInChI 1S C17H15N3O6 c21 14 6 5 12 9 13 14 17 25 26 20 19 11 3 1 10 2 4 11 16 24 18 8 7 15 22 23 h1 6,9,21H,7 8H2, H,18,24 H,22,23 H,25,26 b20 19 StdInChIKey Ref stdinchicite correct chemspider StdInChIKey IPOKCKJONYRRHP FMQUCBEESA N Balsalazide is an anti inflammatory drug used in the treatment of inflammatory bowel disease . It is sold under the name Colazal in the US and Colazide in the UK. It is also sold in generic form in the US by several generic manufacturers. It is usually administered as the disodium salt. Balsalazide releases mesalazine , also known as 5 aminosalicylic acid, or 5 ASA, ref cite pmid 11709512 ref in the large intestine. Its advantage over that drug in the treatment of ulcerative colitis is believed to be the delivery of the active agent past the small intestine to the large intesti ... more details
depends on what form it consists of. For example, mesalazine is more useful in ulcerative colitis ... , or 6 mercaptopurine . More commonly, treatment of IBD requires a form of mesalazine ... to a lighter drug to keep the disease in remission, such as Asacol , a mesalazine . If unsuccessful, a combination of the aforementioned immunosuppression drugs with a mesalazine which may also have ... coli Nissle 1917 is as effective as with standard mesalazine journal Gut volume 53 issue 11 pages ... more details
Drugbox Verifiedfields changed verifiedrevid 462265233 IUPAC name 5 2 Z 2 3 carboxy 4 oxocyclohexa 2,5 dien 1 ylidene hydrazino 2 hydroxybenzoic acid image Olsalazine.png Clinical data tradename Dipentum Drugs.com drugs.com monograph dipentum MedlinePlus a601088 pregnancy AU A B1 B2 B3 C D X pregnancy US C A B C D X pregnancy category legal AU Unscheduled S2 S3 S4 S5 S6 S7 S8 S9 legal CA Schedule I, II, III, IV, V, VI, VII, VIII legal UK GSL P POM CD Class A, B, C legal US Rx only OTC Rx only Schedule I, II, III, IV, V legal status routes of administration Pharmacokinetic data bioavailability protein bound 99 metabolism elimination half life 0.9 hours excretion Identifiers CASNo Ref cascite correct CAS CAS number Ref cascite correct ?? CAS number 15722 48 2 ATC prefix A07 ATC suffix EC03 PubChem 6003770 DrugBank Ref drugbankcite correct drugbank DrugBank DB01250 ChemSpiderID Ref chemspidercite correct chemspider ChemSpiderID 10642377 UNII Ref fdacite correct FDA UNII ULS5I8J03O KEGG Ref keggcite changed kegg KEGG D00727 ChEMBL Ref ebicite changed EBI ChEMBL 571540 Chemical data chemical formula C 14 H 10 N 2 O 6 molecular weight 302.239g mol smiles O C O c1cc ccc1O N N c2cc C O O c O cc2 InChI 1 C14H10N2O6 c17 11 3 1 7 5 9 11 13 19 20 15 16 8 2 4 12 18 10 6 8 14 21 22 h1 6,17 18H, H,19,20 H,21,22 b16 15 InChIKey QQBDLJCYGRGAKP FOCLMDBBBJ StdInChI Ref stdinchicite correct chemspider StdInChI 1S C14H10N2O6 c17 11 3 1 7 5 9 11 13 19 20 15 16 8 2 4 12 18 10 6 8 14 21 22 h1 6,17 18H, H,19,20 H,21,22 b16 15 StdInChIKey Ref stdinchicite correct chemspider StdInChIKey QQBDLJCYGRGAKP FOCLMDBBSA N Olsalazine is an anti inflammatory drug used in the treatment of Inflammatory Bowel Disease such as Ulcerative Colitis . It is sold under the name Dipentum. The chemical name is 3,3 azobis 6 hydroxybenzoate salicylic acid. It is sold as the disodium salt. Like Balsalazide , Olsalazine is believed to deliver Mesalazine , or 5 aminosalicylic acid 5 ASA , past the small intestine, dire ... more details
1617 1623. Kruis W et al. Double blind comparison of an oral Escherichia coli preparation and mesalazine ... BJ et al. Non pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative ... more details
,study found Andrographis paniculata as effective as mesalazine mesalamine in ulcerative colitis. ref ... extract HMPL 004 in active ulcerative colitis A double blind comparison with sustained release mesalazine ... more details
of H 15 extract is not inferior to mesalazine Considering both safety and efficacy of Boswellia serrata extract H15 it appears to be superior over mesalazine in terms of a benefit risk evaluation ... more details
years. In 1977, Mastan S. Kalsi et al. determined that 5 aminosalicylic acid 5 ASA and mesalazine was the therapeutically ... ref Use of a transdermal nicotine patch without the addition of other standard treatments such as mesalazine ... more details
and mesalazine 5 ASAs . ref cite journal title Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine first W ... more details
Infobox disease Name Crohn s disease Latin morbus Le niowski Crohn Image Patterns of CD.svg Caption The three most common sites of intestinal involvement in Crohn s disease are ileum ileal , ileocolic and Colon anatomy colonic . ref name Baumgart DiseasesDB 3178 ICD10 ICD10 K 50 k 50 ICD9 ICD9 555 ICDO OMIM 266600 MedlinePlus 000249 eMedicineSubj med eMedicineTopic 477 eMedicine mult eMedicine2 ped 507 eMedicine2 radio 197 MeshID D003424 Crohn s disease , also known as regional enteritis , is a type of inflammatory bowel disease that may affect any part of the gastrointestinal tract from mouth to anus , causing a wide variety of symptom s. It primarily causes abdominal pain , diarrhea PLEASE SEE WP ENGVAR DO NOT CHANGE THE SPELLING, AS IT INTERFERES WITH LINKING AND IS INAPPROPRIATE which may be bloody if inflammation is at its worst , vomiting can be continuous , or weight loss , ref name Baumgart cite journal author Baumgart DC, Sandborn WJ date 12 May 2007 title Inflammatory bowel disease clinical aspects and established and evolving therapies. journal The Lancet volume 369 issue 9573 pages 1641 57 pmid 17499606 doi 10.1016 S0140 6736 07 60751 X ref ref http www.mayoclinic.com health crohns disease DS00104 DSECTION symptoms Mayo Clinic Crohn s Disease ref ref http digestive.niddk.nih.gov ddiseases pubs crohns National Digestive Diseases Information Clearinghouse ref but may also cause complications outside the gastrointestinal tract such as skin rashes , arthritis , uveitis inflammation of the eye , tiredness, and lack of concentration. ref name Baumgart Crohn s disease is caused by interactions between environmental, immunological and bacterial factors in genetically susceptible individuals. ref cite journal last Cho first JH coauthors Brant, SR title Recent insights into the genetics of inflammatory bowel disease. journal Gastroenterology date 2011 May volume 140 issue 6 pages 1704 12 pmid 21530736 ref ref name Bact08 ref cite journal last Stefanelli first T co ... more details